Exhibitors

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
NL Netherlands
Stand No: 92C88
Aspen is a global supplier of branded and generic pharmaceutical products as well as infant nutritional and consumer healthcare products in selected territories. In line with the Group's commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential.The group has an extensive global presence with more than 10,000 employees. Aspen has a strong presence in both emerging and developed countries with more than ???????60 established business operations in approximately 50 countries. The Group supplies medicines and products to more than 150 countries. Aspen Oss B.V., established in 1923, is a leading global supplier of Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. Aspen Oss specializes in the manufacture of highly complex APIs and is dedicated to the production of high quality APIs. Our customers benefit from...
Location:
Sub-event: CPHI
Zone: API
ES Spain
Stand No: 90C72
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
Location:
LV Latvia
Stand No: 92G80
Grindeks is a vertically integrated pharmaceutical company from Latvia specializing in cardiovascular, CNS and anti-cancer products. Our portfolio of FDFs includes original products and generics. Currently Grindeks produces 24 APIs. Products are exported to 60 markets: of which EU, Japan, Russia and the USA are the main markets.
Location:
Nutra is a pioneer manufacturer of unique niche APIs and have 3 COS Approval, 1 MHRA Approval and 2 Korean FDA Approvals. We are also simultaneously working on USFDA, ANVISA and Chinese SFDA for our key product Olmesartan Medoxomil. We are leaders in Warfarin Sodium, Tetracaine HCL and Olmesartan along with upcoming gliptin molecules. We have WHO GMP and ISO 9001:2008 certification and focus on stringent quality standards and continously upgrade our manufacturing technology to upkeep the competitive industry. We have crossed a revenue of USD 15Mn and have over 160 Employees and are aiming to be Leading Niche Manufacturer.
Location:
Sub-event: CPHI
Zone: API
CN China
Stand No: 101B43NEP
New
Ninth Water is a China based, innovative company driven by our passion in techniques and insights into rising market needs. We create unique value to our customers by providing essential products and service with highest industrial standard. Biopharmaceutical, analytical and performance chemicals are our core markets. Our management team comes from most reputable chemical and pharm companies like Dow Chemical, Sinopec and J&J. We started our business from 2014 and supply high purity acetonitrile to pharmaceutical and analytical customers since then. We are No. 1 HPLC grade ACN manufacturer (3000t capacity) in China since then. Besides high purity solvents, we also provide HPLC solvents reuse equipment (with our partner CNOOC), bringing over 30% solvents saving for peptide purification. Ninth Water has strong interests in biopharmaceuticals. Besides supplying the consumables, we continuously invest on research projects specifically of regulation peptides that stimulate the vaccine immune response, along with professors from Fudan...
Location:
Sub-event: CPHI
Zone: API